Dependence of treatment planning accuracy in peptide receptor radionuclide therapy on the sampling schedule

3Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Peptide receptor radionuclide therapy (PRRT) plays an important role in the treatment of neuroendocrine tumors (NET). Pre-therapeutic dosimetry using the area under the measured time-activity curve (AUC) is important. The sampling schedule for this dosimetry determines the accuracy and reliability of the obtained AUC.

Cite

CITATION STYLE

APA

Maaß, C., Sachs, J. P., Hardiansyah, D., Mottaghy, F. M., Kletting, P., & Glatting, G. (2016). Dependence of treatment planning accuracy in peptide receptor radionuclide therapy on the sampling schedule. EJNMMI Research, 6(1). https://doi.org/10.1186/s13550-016-0185-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free